Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Heartseed, Inc. ( (JP:219A) ) has shared an update.
Heartseed Inc. reported significant financial improvements for the nine months ending July 31, 2025, with net sales reaching ¥1,919 million compared to ¥153 million in the previous year. This positive shift indicates a strong recovery and growth trajectory, enhancing the company’s market position and potentially benefiting its stakeholders.
The most recent analyst rating on (JP:219A) stock is a Hold with a Yen3791.00 price target. To see the full list of analyst forecasts on Heartseed, Inc. stock, see the JP:219A Stock Forecast page.
More about Heartseed, Inc.
Heartseed Inc. is a company listed on the Tokyo Stock Exchange, operating in the biotechnology sector. It focuses on developing innovative treatments for heart diseases, leveraging advanced research and technology to address unmet medical needs.
Average Trading Volume: 945,160
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen86.34B
Find detailed analytics on 219A stock on TipRanks’ Stock Analysis page.